JYMEDukumema ngobuqotho ukuthi uhlanganyele nathi Embukisweni Wezithako ze-PCHi we-2025 e-Guangzhou ukuze uhlole izitayela zemakethe zakamuva, ubuchwepheshe obusha, nemithetho yamazwe ngamazwe. Sivakashele kuIdatha ye-6J07!
UMbukiso we-Guangzhou PCHi wezi-2025 uzobanjwa kusukela mhla ziyi-19 kuya zingama-21 e-China Import and Export Fair Complex (Pazhou). Njengoba uthatha indawo engamamitha-skwele angu-60,000, lo mcimbi kulindeleke ukuthi uhehe izivakashi ezingu-30,000 kanye nababukisi abangu-800 nemikhiqizo.
Njengenkundla ephambili yomhlaba wonke yokuqanjwa kabusha kwesithako, i-PCHi 2025 izofaka abadlali bemboni abahamba phambili abafana noClariant, i-Ashland, i-Gattefossé, ne-Croda, ikhombisa impumelelo yabo ye-R&D esezingeni eliphezulu kanye nobuchwepheshe obuphambili.
Mayelana no-Jymed
I-Shenzhen Jianyuan Pharma Co., Ltd. iyibhizinisi lobuchwepheshe obuphezulu be-biotechnology elisebenza ngokukhethekile ku-R&D ezimele, ukukhiqiza, ukuthengisa, kanye nezinsizakalo ze-CDMO zemikhiqizo esekwe ku-peptide. Sizibophezele ekuletheni izithako ezisebenzayo zemithi ye-peptide (ama-API) nezixazululo ezenziwe ngezifiso emhlabeni jikelele, iphothifoliyo yethu ihlanganisa inqwaba yama-API e-peptide. Imikhiqizo esemqoka efana ne-Semaglutide ne-Tirzepatide isiqedile ukufakwa kwe-US FDA DMF, ithola iziqu zokufinyelela emakethe yamazwe ngamazwe.
I-Hubei JXBio Pharmaceutical yethu ifakwe imigqa yokukhiqiza yesimanje ye-peptide API ethobelana ne-US FDA, EU EMA, kanye namazinga e-China NMPA cGMP yaseChina, okuhlanganisa imigqa yokukhiqiza eyi-10 emikhulu neyindiza yokuhlola. Sibambelela Ohlelweni Oluqinile Lokuphathwa Kwekhwalithi Yemithi (i-QMS) kanye Nohlelo Lokulawulwa Kwemvelo, Ezempilo, Nokuphepha (EHS), oluqinisekisa ukuthobelana ekugcineni namazinga omhlaba. Le nkampani iphumelele ngempumelelo ukuhlolwa kokuthobela kwe-GMP okwenziwa yi-US FDA kanye ne-NMPA yaseChina, kanye nokuhlolwa kwe-EHS okuvela kubaholi bezemithi bomhlaba wonke, okugcizelela ukusebenza kahle kwethu kwekhwalithi, ukuphepha, nokusimama.
Izindawo Zebhizinisi Eziyinhloko
- Ukusekelwa kokubhaliswa komhlaba wonke kwama-API we-peptide
- Ama-peptide ezilwane/izimonyo
- Ukuhlanganiswa kwe-peptide yangokwezifiso nge-CRO, i-CMO, nezinsizakalo ze-OEM
- Ukuthuthukiswa Kwezidakamizwa ze-PDC (Peptide-Radionuclide, Peptide-Small Molecule, Peptide-Protein, Peptide-RNA Conjugates)
Xhumana nathi
Ikheli: Floors 8 & 9, Building 1, Shenzhen Biomedical Innovation Industrial Park, 14 Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen
I-Global API kanye nemibuzo yezimonyo: Inombolo yocingo: +86-15013529272;
Ukubhaliswa kwe-API & Izinsizakalo ze-CDMO (imakethe yase-USA EU）: +86-15818682250
E-mail: jymed@jymedtech.com
Isikhathi sokuthumela: Feb-21-2025
